GlassScriptPhysician profile
Gaurav Patel
NPI 1376922476
$4,262.49
in general payments reported to CMS, 2019-2025
23 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $513 · 2021: $1,188 · 2022: $1,501 · 2023: $185 · 2024: $168 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $916.74 | 2021-2022 | |
| Edwards Lifesciences Corporation | $509.20 | 2022 | |
| Boston Scientific Corporation | $331.20 | 2019-2024 | Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $326.46 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $243.27 | 2019-2024 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $240.49 | 2021 | |
| Abbott Laboratories | $227.31 | 2021 | |
| Pfizer INC. | $215.23 | 2019-2024 | |
| Chiesi USA, INC. | $207.15 | 2021-2022 | |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Eisai INC. | $111.58 | 2019 | |
| Esperion Therapeutics, INC. | $102.38 | 2020 | |
| Inari Medical, INC. | $99.22 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $99.00 | 2019 | |
| Abiomed | $98.61 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $95.94 | 2025 | |
| Shockwave Medical, INC | $81.60 | 2021 | |
| Zoll Circulation INC | $75.88 | 2021 | |
| Harmony Biosciences LLC | $58.78 | 2021 | |
| Cvrx, INC. | $33.55 | 2025 | Barostim Neo System |
| Inspire Medical Systems, INC. | $26.90 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $23.29 | 2019 | |
| Novo Nordisk INC | $14.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.